Pain Medicine, Interventional Pain Medicine · Pomona, CA
NPI
1467512624
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
250 W Bonita Ave, Suite 160
Pomona, CA, 91767
Phone (909) 593-1002
Groups this clinician bills Medicare through
Medicare paid, 2024
$261K
4,118 services
Medicare patients, 2024
344
Average age 71
Drug cost, 2024
$55K
3,479 prescriptions
Company payments, 2025
$279
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bryan X Lee was code 99442 (telephone services), 1,293 times for 278 patients. In total Bryan X Lee billed 4,118 services in 49 codes, and Medicare paid $261K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99442 Telephone Services | Office | 1,293 | 278 | $72.96 | $94K |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 417 | 83 | $0.50 | $208 |
| 99213 Office E&M - Established | Office | 385 | 214 | $76.91 | $30K |
| 99214 Office E&M - Established | Office | 353 | 203 | $103.89 | $37K |
| 96372 Injection Administration | Office | 212 | 86 | $12.05 | $2,554 |
| 99443 Telephone Services | Office | 165 | 97 | $103.50 | $17K |
| 99152 Anesthesia | Facility | 156 | 76 | $9.56 | $1,491 |
| 27096 Joint Injection | Facility | 148 | 78 | $97.17 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 114 | 94 | $13.51 | $1,540 |
| 99441 Telephone Services | Office | 95 | 62 | $47.89 | $4,549 |
| 62323 Nerve Block Injection - Back | Facility | 88 | 79 | $77.26 | $6,799 |
| 99204 Office E&M - New | Office | 79 | 79 | $137.24 | $11K |
| 77002 Imaging - Miscellaneous | Facility | 64 | 32 | $21.18 | $1,356 |
| 20610 Joint Injection | Facility | 55 | 27 | $45.67 | $2,512 |
| 64635 Destruction by Neurolytic Agent - Back | Facility | 54 | 33 | $154.97 | $8,369 |
By year: 2022 $241K for 3,939 services; 2023 $247K for 4,080 services; 2024 $261K for 4,118 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bryan X Lee prescribed most often to Medicare patients was Gabapentin, with 683 prescriptions and refills. In total Bryan X Lee wrote 3,479 Medicare prescriptions that cost $55K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 683 | 698 | 188 | $4,680 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 576 | 593 | 231 | $9,920 |
| Baclofen Generic | 383 | 392 | 127 | $2,457 |
| Tizanidine Hcl Generic | 368 | 382 | 118 | $1,860 |
| Diclofenac Sodium Generic | 316 | 317 | 143 | $5,959 |
| Duloxetine Hcl Generic | 293 | 310 | 95 | $3,685 |
| Lidocaine Generic | 139 | 143 | 51 | $9,624 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 90 | 90 | 49 | $795 |
| Pregabalin Generic | 61 | 69 | 23 | $776 |
| Meloxicam Generic | 61 | 61 | 24 | $95.01 |
| Ibuprofen Generic | 58 | 59 | 15 | $187 |
| Topiramate Generic | 48 | 53 | 17 | $680 |
| Methocarbamol Generic | 47 | 47 | 14 | $231 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 35 | 35 | 18 | $618 |
| Omeprazole Generic | 33 | 33 | Under 11 | $125 |
Brand drugs: 35 claims; generic drugs: 3,444 claims; opioid claims: 158.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bryan X Lee $279 ($279 in general payments such as food, travel and fees) from 2 companies. The largest payer was Curonix LLC with $154.
| Company | Payments | Amount |
|---|---|---|
| Curonix LLC | 3 | $154 |
| Abbvie Inc. ABBV | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.